Privium Fund Management’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $819K | Buy |
197,458
+66,458
| +51% | +$276K | 0.18% | 37 |
|
|
2025
Q1 | $423K | Buy |
131,000
+10,000
| +8% | +$32.3K | 0.11% | 45 |
|
|
2024
Q4 | $674K | Buy |
121,000
+22,500
| +23% | +$125K | 0.15% | 39 |
|
|
2024
Q3 | $1.06M | Buy |
98,500
+58,500
| +146% | +$632K | 0.26% | 34 |
|
|
2024
Q2 | $823K | Buy |
40,000
+9,000
| +29% | +$185K | 0.21% | 48 |
|
|
2024
Q1 | $988K | Sell |
31,000
-2,680
| -8% | -$85.4K | 0.26% | 43 |
|
|
2023
Q4 | $716K | Hold |
33,680
| – | – | 0.2% | 51 |
|
|
2023
Q3 | $429K | Buy |
+33,680
| New | +$429K | 0.13% | 61 |
|